A review of long-term prophylaxis in the rare inherited coagulation factor deficiencies

Area of Science:

• Hematology
• Genetics
• Internal Medicine

Background:

• Rare inherited coagulation factor deficiencies (e.g., Factors I, II, V, VII, XI, XIII, combined FV+FVII, vitamin K-dependent factors, von Willebrand disease type 3) are associated with significant bleeding risks.
• These conditions, with an aggregate prevalence of ~1:100,000, can lead to life- or function-threatening hemorrhage.
• Effective management strategies are crucial for improving patient outcomes.

Purpose of the Study:

• To review the existing literature on long-term prophylaxis for rare inherited coagulation factor deficiencies.
• To provide evidence-based recommendations for prophylaxis in these rare bleeding disorders.
• To address the critical need for standardized long-term management approaches.

Main Methods:

• Systematic literature search for studies on long-term prophylaxis in rare coagulation factor deficiencies.
• Analysis of available data regarding efficacy and safety of prophylactic treatments.
• Synthesis of findings to formulate clinical recommendations.

Main Results:

• Literature on long-term prophylaxis for many of these rare deficiencies is limited.
• Prophylaxis is a key strategy to prevent recurrent bleeding and preserve function.
• Specific recommendations are provided where sufficient evidence exists.

Conclusions:

• Long-term prophylaxis is essential for managing rare inherited coagulation factor deficiencies.
• Further research is needed to establish optimal prophylactic regimens for all deficiencies.
• Recommendations aim to guide clinical practice and improve patient care.